This WEBINAR discusses the new classification of LGMDs and maps the current classification to the previous one, explaining the rationale of the updates that were done. It includes therefore a ample discussion of disease causes, mechanisms and ontologies to enable a smoother transition to the new classification system for LGMD sub-types that hopefully is most useful to patients, researchers and clinicians and complies with classification systems established by OMIM (Online Mendelian Inheritance in Man), Orphanet and ICD (International Classification of Diseases)-11.
Volker Straub is Harold Macmillan Professor of Medicine and Professor of Neuromuscular Genetics, Newcastle University Deputy Dean, director of the Institute of Translational and Clinical Research Newcastle University and John Walton Muscular Dystrophy Research Centre Honorary Consultant in Clinical Genetics.
He trained as a paediatric neurologist at the University of Dussledorf and the University of Essen, Germany. Following this, he completed his PhD on Duchenne muscular dystrophy and took up a postgraduate post in Kevin Campbell’s laboratory at the University of Iowa, on limb girdle muscular dystrophies (LGMD).
Professor Straub’s interest in muscle diseases is in translational research.
He was the co-founder of the EU FP6 funded network TREAT-NMD, which he coordinated with Professor Kate Bushby. He is a long standing core member of the TREAT-NMD TACT committee, which offers guidance on the translation and development path of therapeutics programs in rare neuromuscular diseases.
His current research involves the application of muscle imaging, the use of zebrafish and mouse models, next generation sequencing and other –omics technologies for the characterization of primary neuromuscular disorders.